We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03605368
Previous Study | Return to List | Next Study

VR Intervention to Improve Police Safety

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03605368
Recruitment Status : Recruiting
First Posted : July 30, 2018
Last Update Posted : November 26, 2021
Floreo, Inc.
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Children's Hospital of Philadelphia

Brief Summary:
The primary objective of this study is to demonstrate the efficacy of Floreo's police safety module (PSM) in adolescents and adults with autism spectrum disorder (ASD) by assessing improvement in police interaction skills as compared to a video modeling intervention.

Condition or disease Intervention/treatment Phase
Autism Spectrum Disorder Autism Behavioral: Virtual Reality Intervention Behavioral: Video Modeling Intervention Not Applicable

Detailed Description:
Advances in virtual reality (VR) technology offer new opportunities to design interventions targeting the core deficits associated with autism spectrum disorder (ASD) and promote acquisition of skills necessary for effective navigation of challenging social situations, such as engagement with law enforcement. Researchers have explored the potential of virtual reality technology in targeting autism-related deficits, but at this time there are no evidence-based VR interventions for ASD. While most research labelled VR for the purposes of therapy has not been immersive, in recent years, the commercial introduction of head-mounted displays (HMD) and lower cost of virtual reality technology have led to greater interest in therapeutic applications of VR. As part of a mission to develop VR products for individuals with ASD, investigators will collaborate with a commercial tech start-up company, Floreo Technology, to study a mobile VR module for police safety skills. Investigators seek to evaluate the safety and feasibility of the mobile VR police safety module (PSM) and the effectiveness of the module in improving police interaction skills in adolescents and adults with ASD.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 96 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Immersive Virtual Reality as a Tool to Improve Police Safety in Adolescents and Adults With ASD
Actual Study Start Date : November 28, 2017
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : August 2022

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Video Modeling Behavioral: Video Modeling Intervention
The video modeling intervention is a subset of the BE SAFE The Movie Curriculum Lessons (https://besafethemovie.com/curriculum/) that were selected to match Floreo PSM on length. The BE SAFE The Movie Curriculum consists of video-based instruction on police officer interaction expectations and safety. Within each of three sessions, participants will watch videos, complete worksheets, and discuss topics related to police safety knowledge and behaviors with the study administrator.

Experimental: Virtual Reality Intervention Behavioral: Virtual Reality Intervention
Floreo's Police Safety Module (PSM) offers a supervised VR experience for people with ASD. The software is an application that provides a 3D immersive scene for headset-compatible smartphones. The person with ASD will use a smartphone capable of running the application with a dedicated headset providing the virtual environment. The PSM provides an immersive story-based intervention that shows a fully realized and intricately detailed urban environment designed to engage the user in a virtual encounter with a law enforcement officer. The immersive VR environment engages the person with ASD as an actor in a virtual narrative, incorporating strategies from both story-based intervention and video modeling. The video demonstrates the approach and initial engagement efforts of two police officers in the virtual environment, from the perspective of the person wearing the headset. The PSM allows a monitoring therapist to use a tablet or phone to supervise the person's virtual world.

Primary Outcome Measures :
  1. Change in Live Police Interaction Assessment Scores from Pre-to-Post treatment [ Time Frame: Baseline and immediately post-intervention ]
    The primary efficacy endpoint will be the change in Live Police Interaction Assessment Scores between the Virtual Reality Intervention and BE SAFE Video-Based intervention from pre-treatment to post-treatment.

Secondary Outcome Measures :
  1. Change in Police Interaction Knowledge [ Time Frame: Baseline and immediately post-intervention ]
    The secondary endpoint will include changes in Police Interaction Knowledge Questionnaire Scores from Pre-Treatment to Post-Treatment for the Virtual Reality Intervention and BE SAFE Video-Based intervention.

  2. Learned skill improvements - Phase IIb only [ Time Frame: 10 weeks post-intervention ]
    An additional Secondary endpoint is maintenance of learned skill improvements, indexed via the 10-week Follow-Up administration of the Live Police Interaction Assessment (Phase IIb only).

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   12 Years to 60 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Males or females age 12 to 60 years.
  • Documented autism spectrum disorder (ASD) diagnosis
  • Verbal Intelligence Quotient (IQ) >/= 75 (verbal and non-verbal)
  • Informed consent (if adult) or parental/guardian permission (if child or adult with diminished capacity) and, if applicable, assent

Exclusion Criteria:

  • Participation in pilot virtual reality (VR) study at the Children's Hospital of Philadelphia (CHOP)
  • Personal or family history of seizures or a seizure disorder
  • Primary sensory impairment (e.g., blindness, deafness)
  • Personal or family history of migraines
  • History of vertigo
  • History of strabismus, other eye muscle problems, or eye surgery
  • History of concussion with hospitalization
  • Diagnosis of a known genetic syndrome (e.g., Down syndrome, Fragile X syndrome)
  • History of a medical condition which has affected/affects cognitive, sensory, or motor functioning (e.g., Fetal Alcohol Syndrome, brain injury, stroke, brain tumor)
  • Non-English speaking
  • Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03605368

Layout table for location contacts
Contact: Sonny Russell 267-425-1190 russella2@chop.edu
Contact: Jennifer Swope, MS 267-425-1118 swopej@chop.edu

Layout table for location information
United States, Pennsylvania
Children's Hospital of Philadelphia Recruiting
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
Children's Hospital of Philadelphia
Floreo, Inc.
National Institute of Mental Health (NIMH)
Layout table for investigator information
Principal Investigator: Julia Parish-Morris, PhD Children's Hospital of Philadelphia
Principal Investigator: Vijay Ravindran Floreo, Inc.
Layout table for additonal information
Responsible Party: Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier: NCT03605368    
Other Study ID Numbers: 17-014387
1R42MH115539-01 ( U.S. NIH Grant/Contract )
First Posted: July 30, 2018    Key Record Dates
Last Update Posted: November 26, 2021
Last Verified: November 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Children's Hospital of Philadelphia:
Additional relevant MeSH terms:
Layout table for MeSH terms
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders